Differential loss of striatal projection neurons in Huntington disease

Anton Reiner, R. L. Albin, K. D. Anderson, C. J. D'Amato, J. B. Penney, A. B. Young

Research output: Contribution to journalArticle

700 Citations (Scopus)

Abstract

Huntington disease (HD) is characterized by the loss of striatal projection neurons, which constitute the vast majority of striatal neurons. To determine whether there is differential loss among different populations of striatal projection neurons, the integrity of the axon terminal plexuses arising from the different populations of substance P-containing and enkephalin-containing striatal projection neurons was studied in striatal target areas by immunohistochemistry. Analysis of 17 HD specimens indicated that in early and middle stages of HD, enkephalin-containing neurons projecting to the external segment of the globus pallidus were much more affected than substance P-containing neurons projecting to the internal pallidal segment. Furthermore, substance P-containing neurons projecting to the substantia nigra pars reticulata were more affected than those projecting to the substantia nigra pars compacta. At the most advanced stages of the disease, projections to all striatal target areas were depleted, with the exception of some apparent sparing of the striatal projection to the substantia nigra pars compacta. These findings may explain some of the clinical manifestations and pharmacology of HD. They also may aid in identifying the neural defect underlying HD and provide additional data with which to evaluate current models of HD pathogenesis.

Original languageEnglish (US)
Pages (from-to)5733-5737
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume85
Issue number15
DOIs
StatePublished - Jan 1 1988

Fingerprint

Corpus Striatum
Huntington Disease
Neurons
Substance P
Enkephalins
Globus Pallidus
Clinical Pharmacology
Presynaptic Terminals
Immunohistochemistry
Population

All Science Journal Classification (ASJC) codes

  • General

Cite this

Differential loss of striatal projection neurons in Huntington disease. / Reiner, Anton; Albin, R. L.; Anderson, K. D.; D'Amato, C. J.; Penney, J. B.; Young, A. B.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 85, No. 15, 01.01.1988, p. 5733-5737.

Research output: Contribution to journalArticle

Reiner, Anton ; Albin, R. L. ; Anderson, K. D. ; D'Amato, C. J. ; Penney, J. B. ; Young, A. B. / Differential loss of striatal projection neurons in Huntington disease. In: Proceedings of the National Academy of Sciences of the United States of America. 1988 ; Vol. 85, No. 15. pp. 5733-5737.
@article{1aaad708d90c41a29a5d4421757b0ed4,
title = "Differential loss of striatal projection neurons in Huntington disease",
abstract = "Huntington disease (HD) is characterized by the loss of striatal projection neurons, which constitute the vast majority of striatal neurons. To determine whether there is differential loss among different populations of striatal projection neurons, the integrity of the axon terminal plexuses arising from the different populations of substance P-containing and enkephalin-containing striatal projection neurons was studied in striatal target areas by immunohistochemistry. Analysis of 17 HD specimens indicated that in early and middle stages of HD, enkephalin-containing neurons projecting to the external segment of the globus pallidus were much more affected than substance P-containing neurons projecting to the internal pallidal segment. Furthermore, substance P-containing neurons projecting to the substantia nigra pars reticulata were more affected than those projecting to the substantia nigra pars compacta. At the most advanced stages of the disease, projections to all striatal target areas were depleted, with the exception of some apparent sparing of the striatal projection to the substantia nigra pars compacta. These findings may explain some of the clinical manifestations and pharmacology of HD. They also may aid in identifying the neural defect underlying HD and provide additional data with which to evaluate current models of HD pathogenesis.",
author = "Anton Reiner and Albin, {R. L.} and Anderson, {K. D.} and D'Amato, {C. J.} and Penney, {J. B.} and Young, {A. B.}",
year = "1988",
month = "1",
day = "1",
doi = "10.1073/pnas.85.15.5733",
language = "English (US)",
volume = "85",
pages = "5733--5737",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "15",

}

TY - JOUR

T1 - Differential loss of striatal projection neurons in Huntington disease

AU - Reiner, Anton

AU - Albin, R. L.

AU - Anderson, K. D.

AU - D'Amato, C. J.

AU - Penney, J. B.

AU - Young, A. B.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Huntington disease (HD) is characterized by the loss of striatal projection neurons, which constitute the vast majority of striatal neurons. To determine whether there is differential loss among different populations of striatal projection neurons, the integrity of the axon terminal plexuses arising from the different populations of substance P-containing and enkephalin-containing striatal projection neurons was studied in striatal target areas by immunohistochemistry. Analysis of 17 HD specimens indicated that in early and middle stages of HD, enkephalin-containing neurons projecting to the external segment of the globus pallidus were much more affected than substance P-containing neurons projecting to the internal pallidal segment. Furthermore, substance P-containing neurons projecting to the substantia nigra pars reticulata were more affected than those projecting to the substantia nigra pars compacta. At the most advanced stages of the disease, projections to all striatal target areas were depleted, with the exception of some apparent sparing of the striatal projection to the substantia nigra pars compacta. These findings may explain some of the clinical manifestations and pharmacology of HD. They also may aid in identifying the neural defect underlying HD and provide additional data with which to evaluate current models of HD pathogenesis.

AB - Huntington disease (HD) is characterized by the loss of striatal projection neurons, which constitute the vast majority of striatal neurons. To determine whether there is differential loss among different populations of striatal projection neurons, the integrity of the axon terminal plexuses arising from the different populations of substance P-containing and enkephalin-containing striatal projection neurons was studied in striatal target areas by immunohistochemistry. Analysis of 17 HD specimens indicated that in early and middle stages of HD, enkephalin-containing neurons projecting to the external segment of the globus pallidus were much more affected than substance P-containing neurons projecting to the internal pallidal segment. Furthermore, substance P-containing neurons projecting to the substantia nigra pars reticulata were more affected than those projecting to the substantia nigra pars compacta. At the most advanced stages of the disease, projections to all striatal target areas were depleted, with the exception of some apparent sparing of the striatal projection to the substantia nigra pars compacta. These findings may explain some of the clinical manifestations and pharmacology of HD. They also may aid in identifying the neural defect underlying HD and provide additional data with which to evaluate current models of HD pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0001589776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0001589776&partnerID=8YFLogxK

U2 - 10.1073/pnas.85.15.5733

DO - 10.1073/pnas.85.15.5733

M3 - Article

C2 - 2456581

AN - SCOPUS:0001589776

VL - 85

SP - 5733

EP - 5737

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 15

ER -